Loading clinical trials...
Loading clinical trials...
Combination Anti-thrombotic Treatment for Prevention of Recurrent Ischemic Stroke in Intracranial Atherosclerotic Disease: Protocol for a Pilot Randomized Trial
Conditions
Interventions
Rivaroxaban 2.5 Mg Oral Tablet bid
Acetylsalicyclic acid 81 mg tablet qd
Locations
10
Canada
Alberta Health Services
Calgary, Alberta, Canada
University of Alberta
Edmonton, Alberta, Canada
Vancouver General Hospital
Vancouver, British Columbia, Canada
Hamilton Health Sciences
Hamilton, Ontario, Canada
Kingston Health Sciences Centre
Kingston, Ontario, Canada
London Health Sciences Centre
London, Ontario, Canada
Start Date
February 3, 2020
Primary Completion Date
September 18, 2023
Completion Date
September 18, 2023
Last Updated
September 26, 2023
NCT07371455
NCT07253181
NCT06990867
NCT07001267
NCT07004673
NCT03153683
Lead Sponsor
Population Health Research Institute
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions